Fundz

Torrey Pines Medicine secures an angel round led by Lotus Lake Capital to raise tens of millions of RMB for its ultra-long-acting peptide therapeutics. The funding will expedite the development of TPM004 and the PepTetris™ platform.

PRIVATEJul 28, 2026

Round Type

Angel

ShenzhenBiotechnologyHealth CareTherapeutics

Investors

Stars CapitalTainuo CapitalBlue Ocean CapitalMr. Yousheng ShenLotus Lake Capital

Description

Torrey Pines Medicine has successfully completed an angel financing round raising tens of millions of RMB to advance its peptide therapeutics. The round was led by Lotus Lake Ventures, with participation from Stars Capital, Tainuo Capital, and Blue Ocean Capital. The proceeds will support IND filing and clinical trials for TPM004 and refine the PepTetris™ platform. The company's focus remains on addressing unmet clinical needs in metabolic diseases.

Quick answer

Torrey Pines Medicine raised an undisclosed amount in a Angel round, dated July 28, 2026. Investors: Stars Capital, Tainuo Capital, Blue Ocean Capital, Mr. Yousheng Shen and Lotus Lake Capital. Torrey Pines Medicine is based in Shenzhen, Guangdong, China.

How much did Torrey Pines Medicine raise?
Torrey Pines Medicine raised an undisclosed amount in a Angel round on July 28, 2026.
Who invested in Torrey Pines Medicine?
Stars Capital, Tainuo Capital, Blue Ocean Capital, Mr. Yousheng Shen and Lotus Lake Capital are named as investors in this round.
What does Torrey Pines Medicine do?
Torrey Pines Medicine is a pre-clinical-stage biotechnology company incubated by Shenzhen Bay Laboratory, dedicated to developing next-generation ultra-long-acting peptide therapeutics for obesity, type 2 diabetes,..
Where is Torrey Pines Medicine based and how big is it?
Torrey Pines Medicine is based in Shenzhen, Guangdong, China. Fundz records about 44 employees.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Torrey Pines Medicine that raised within 45 days of this round, from Fundz verified event records.

  • Cerenome, Inc. raised $3M (Post-IPO Equity) on September 10, 2026.
  • CONNECTA Therapeutics raised $3.6M (Seed) on September 10, 2026.
  • Cerenome, Inc. raised $20M (Debt Financing) on September 10, 2026.
  • Navion Neurosciences raised $11M (Seed) on September 9, 2026.
  • Encoded Therapeutics raised $275M (Series F) on September 9, 2026.
  • Newron Pharmaceuticals S.p.A. & EA Pharma Ltd raised $6.4M on September 8, 2026.

Who to call at Torrey Pines Medicine, and when

A new round usually means Torrey Pines Medicine is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Torrey Pines Medicine raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Torrey Pines Medicine, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Torrey Pines Medicine. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Torrey Pines Medicine

Location

Shenzhen, Guangdong, China

About

Torrey Pines Medicine is a pre-clinical-stage biotechnology company incubated by Shenzhen Bay Laboratory, dedicated to developing next-generation ultra-long-acting peptide therapeutics for obesity, type 2 diabetes, metabolic dysfunction-associated steatotic liver disease (MASLD), and other chronic metabolic diseases. The company focuses on addressing key clinical unmet needs in the field of metabolic diseases through their proprietary PepTetris™ peptide discovery platform. Their lead program involves TPM004, a differentiated ultra-long-acting amylin/calcitonin receptor dual agonist.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Torrey Pines Medicine raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Torrey Pines Medicine's next move

See what Strategic adds

Torrey Pines Medicine raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.